Trials / Completed
CompletedNCT06317584
Empowerment-based Complementary and Alternative Medicine (ECAM)
The Establishment of "Empowerment-based Complementary and Alternative Medicine (ECAM) " Educational Program to Improve Complementary and Alternative Medicine(CAM) Health Literacy in Patients With Diabetes: Dilemma Analysis, Integration Into Practice and Outcome Evaluation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Chang Gung University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.
Detailed description
The objectives of this phase study are to (1) implement the ECAM educational app to empower patients with diabetes in their management of diabetes alongside CAM use; (2) examine the impact of the ECAM educational app on patient empowerment, CAM health literacy, risk management of CAM use, CAM communication and diabetes quality of life in patients with diabetes; and (3) collect feedback from both patients and nurses on how to improve the ECAM educational app for dissemination and implementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental: Empowerment Application for CAM Health Education | Using empowerment software application for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of assistive tool of the empowerment software application |
| OTHER | Written Paper for CAM Health Education | Using written paper for complementary and alternative therapy education and explaining the risk factors that need to be considered |
Timeline
- Start date
- 2024-05-17
- Primary completion
- 2024-08-16
- Completion
- 2025-01-03
- First posted
- 2024-03-19
- Last updated
- 2025-04-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06317584. Inclusion in this directory is not an endorsement.